a public good project by the
Synthesis
Company
of California

© 2026

Eduard J. van Beers | doi.page

0 works0 citations0 h-index

Eduard J. van Beers

Utrecht University(NL)University Medical Center Utrecht(NL)

Publications by Year

Research Areas

Hemoglobinopathies and Related Disorders, Erythrocyte Function and Pathophysiology, Blood groups and transfusion, Iron Metabolism and Disorders, Blood disorders and treatments

Most-Cited Works

→ Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease(2009)267 cited
→ Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study(2018)161 cited
→ Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency(2019)156 cited
→ Patient‐controlled analgesia versus continuous infusion of morphine during vaso‐occlusive crisis in sickle cell disease, a randomized controlled trial(2007)118 cited
→ Iron, Inflammation, and Early Death in Adults With Sickle Cell Disease(2014)97 cited
→ Mitapivat versus Placebo for Pyruvate Kinase Deficiency(2022)91 cited
→

Sickle cell disease: Clinical presentation and management of a global health challenge

(2019)

89 cited

→ Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency(2018)88 cited

→ Cerebrovascular reserve capacity is impaired in patients with sickle cell disease(2009)77 cited

→ AG-348 (Mitapivat), an allosteric activator of red blood cell pyruvate kinase, increases enzymatic activity, protein stability, and ATP levels over a broad range of PKLR genotypes(2020)75 cited